- Home
- NXTC vs GWAV Comparison
NXTC vs GWAV Comparison
Compare NXTC & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- GWAV
- Stock Information
- Founded
- NXTC 2015
- GWAV 2002
- Country
- NXTC United States
- GWAV United States
- Employees
- NXTC N/A
- GWAV N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- GWAV Packaged Foods
- Sector
- NXTC Health Care
- GWAV Consumer Staples
- Exchange
- NXTC Nasdaq
- GWAV Nasdaq
- Market Cap
- NXTC 12.8M
- GWAV 12.8M
- IPO Year
- NXTC 2019
- GWAV N/A
- Fundamental
- Price
- NXTC $5.12
- GWAV $0.18
- Analyst Decision
- NXTC Strong Buy
- GWAV
- Analyst Count
- NXTC 2
- GWAV 0
- Target Price
- NXTC $25.50
- GWAV N/A
- AVG Volume (30 Days)
- NXTC 318.4K
- GWAV 1.8M
- Earning Date
- NXTC 08-07-2025
- GWAV 08-22-2025
- Dividend Yield
- NXTC N/A
- GWAV N/A
- EPS Growth
- NXTC N/A
- GWAV N/A
- EPS
- NXTC N/A
- GWAV N/A
- Revenue
- NXTC N/A
- GWAV $33,315,859.00
- Revenue This Year
- NXTC N/A
- GWAV N/A
- Revenue Next Year
- NXTC N/A
- GWAV N/A
- P/E Ratio
- NXTC N/A
- GWAV N/A
- Revenue Growth
- NXTC N/A
- GWAV N/A
- 52 Week Low
- NXTC $2.69
- GWAV $0.12
- 52 Week High
- NXTC $19.80
- GWAV $1.09
- Technical
- Relative Strength Index (RSI)
- NXTC 48.99
- GWAV 40.27
- Support Level
- NXTC $4.75
- GWAV $0.18
- Resistance Level
- NXTC $5.23
- GWAV $0.19
- Average True Range (ATR)
- NXTC 0.31
- GWAV 0.01
- MACD
- NXTC 0.02
- GWAV -0.00
- Stochastic Oscillator
- NXTC 53.28
- GWAV 11.69
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About GWAV Greenwave Technology Solutions Inc.
Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.